Ignasi Nart-Figueras
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials.
Journal: The Journal of dermatological treatment
Published: May 11, 2026
Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.
Journal: Acta dermato-venereologica
Published: March 11, 2026
Combination of advanced systemic therapy in atopic dermatitis: A multicentre observational study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 24, 2026
Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.
Journal: International journal of dermatology
Published: January 10, 2026
Anifrolumab for lupus erythematosus in real-world practice: A Spanish national series.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 03, 2026
Experience in the management of real-world patients with chronic prurigo nodularis in a dermatology setting: results from the ECOSPIN Spanish survey-based study.
Journal: Frontiers in medicine
Published: December 16, 2025
Real-World Use of Baricitinib in Patients with Atopic Dermatitis in Spain: DAMA-S Study, A Retrospective Chart Review.
Journal: Dermatology and therapy
Published: October 24, 2025
Upadacitinib dose increase to 45 mg daily for refractory atopic dermatitis.
Journal: Journal of the American Academy of Dermatology
Published: October 21, 2025
Chronic Prurigo: Current Knowledge, Treatment Strategies, Future Perspectives, and Unmet Needs.
Journal: Acta dermato-venereologica
Published: July 02, 2025
Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities.
Journal: International journal of molecular sciences
Published: April 07, 2025
Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin.
Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin.
Journal: Frontiers in immunology
Published: March 25, 2025
Effectiveness and safety in the use of Janus kinase inhibitors in combination with other classic or biological systemic treatments: real-world clinical practice experience.
Journal: Actas dermo-sifiliograficas
Published: July 23, 2024
Last Updated: 09/26/2026